Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02066389
What this trial is testing

A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 300
Large-scale testing (Phase 3)Study completedNCT00410410
What this trial is testing

Abatacept in Patients With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 591
Testing effectiveness (Phase 2)Study completedNCT00950989
What this trial is testing

Brodalumab (AMG 827) in Rheumatoid Arthritis (RA) Participants With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Amgen 252
Testing effectiveness (Phase 2)Study completedNCT03355872
What this trial is testing

A Randomised, Double-blind, Phase I/II Study to Evaluate the PK, PD, Safety, and Efficacy Between HLX01 and Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis and Inadequate Response to Treatment With DMARDs

Who this might be right for
Rheumatoid Arthritis
Shanghai Henlius Biotech 194
Not applicableActive Not RecruitingNCT01787409
What this trial is testing

Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

Who this might be right for
Aggressive Non-Hodgkin LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-Cell Lymphoma+12 more
Mayo Clinic 565
Large-scale testing (Phase 3)Study completedNCT04936308
What this trial is testing

Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 453
Testing effectiveness (Phase 2)Study completedNCT00664716
What this trial is testing

Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Participants

Who this might be right for
Rheumatoid Arthritis
Biogen 391
Large-scale testing (Phase 3)Study completedNCT03796858
What this trial is testing

Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy

Who this might be right for
Arthritis, Psoriatic
Janssen Pharmaceutica N.V., Belgium 285
Large-scale testing (Phase 3)Study completedNCT01153347
What this trial is testing

Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive DisorderDepression
AstraZeneca 2,409
Post-approval studies (Phase 4)Study completedNCT03149991
What this trial is testing

Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

Who this might be right for
Depression
Massachusetts General Hospital 51
Large-scale testing (Phase 3)Ended earlyNCT01764997
What this trial is testing

An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate

Who this might be right for
Rheumatoid Arthritis
Sanofi 776
Post-approval studies (Phase 4)Study completedNCT03835715
What this trial is testing

Study With Vortioxetine on Emotional Functioning in Patients With Depression

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 150
Large-scale testing (Phase 3)Looking for participantsNCT07807865
What this trial is testing

Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)

Who this might be right for
Generalized Anxiety Disorder
Intra-Cellular Therapies, Inc. 900
Large-scale testing (Phase 3)Study completedNCT01587989
What this trial is testing

RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 77
Not applicableStudy completedNCT02856776
What this trial is testing

Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages

Who this might be right for
Vitamin D Insufficiency
Boston University 39
Large-scale testing (Phase 3)Ended earlyNCT01837797
What this trial is testing

Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Who this might be right for
Major Depressive Disorder
H. Lundbeck A/S 129
Large-scale testing (Phase 3)Active Not RecruitingNCT04909801
What this trial is testing

Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 338
Large-scale testing (Phase 3)Study completedNCT00527072
What this trial is testing

PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

Who this might be right for
Psoriasis
Centocor Ortho Biotech Services, L.L.C. 217
Testing effectiveness (Phase 2)Study completedNCT01437657
What this trial is testing

MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy

Who this might be right for
Major Depressive Disorder
Hoffmann-La Roche 319
Large-scale testing (Phase 3)Study completedNCT03968159
What this trial is testing

Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
ACADIA Pharmaceuticals Inc. 298
Next Page